However, the lower risk associated with metformin was borderline significant in the ITT analyses in both age subgroups.
← all excerpts
The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus.
1
—
—